Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists

Abstract Chemical process development is a critical component in the development process for active pharmaceutical ingredients (APIs). With interfaces to drug discovery and API manufacturing, chemical process development activities must deliver scalable, safe, cost‐efficient, sustainable, and reliable processes for novel as well as marketed APIs. Despite its importance for the pharmaceutical industry and society, the domain of chemical process development, together with its advances and challenges, is often not well known to nonpractitioners. As industry scientists, we provide a scientific perspective on the state of affairs in chemical process development, which we believe will be of value to a broader audience, including academic researchers, students, and professionals from related fields.

Authors

Institutions

Publication Details

Journal
Angewandte Chemie
Published
2025-03-27
DOI
https://doi.org/10.1002/ange.202420719
Primary Topic
Chemistry and Chemical Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists

Ulrich Scholz, Carl F. Nising, André P. Dieskau, Joerg Gries et al.
Angewandte Chemie
Chemistry and Chemical Engineering
article

Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists

Ulrich Scholz, Carl F. Nising, André P. Dieskau, Joerg Gries, Stefan Hildbrand, Hilmar Weinmann, Oliver Block, Joachim I. Krueger, Jorma Hassfeld, Daniel Kaufmann, Juan R. Dehli, Robert Moeckel, Volker Kraft
article en

Abstract

Abstract Chemical process development is a critical component in the development process for active pharmaceutical ingredients (APIs). With interfaces to drug discovery and API manufacturing, chemical process development activities must deliver scalable, safe, cost‐efficient, sustainable, and reliable processes for novel as well as marketed APIs. Despite its importance for the pharmaceutical industry and society, the domain of chemical process development, together with its advances and challenges, is often not well known to nonpractitioners. As industry scientists, we provide a scientific perspective on the state of affairs in chemical process development, which we believe will be of value to a broader audience, including academic researchers, students, and professionals from related fields.

Angewandte ChemieVol. 137(19)
Roche (Switzerland) (CH), Novartis (Switzerland) (CH), Boehringer Ingelheim (Germany) (DE), Merck KGaA, Darmstadt (Germany) (DE), Sanofi (Germany) (DE), Bayer (Germany) (DE)
Openalex Percentile: Top 93%
Chemistry and Chemical Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.